ABSENCE OF SIDE EFFECTS;
ADULT;
ANAMNESIS;
ANTIBODY DETECTION;
BONE METASTASIS;
BREAST CARCINOMA;
CANCER CHEMOTHERAPY;
CANCER RELAPSE;
CASE REPORT;
CLINICAL FEATURE;
DRUG INDUCED DISEASE;
DRUG RESPONSE;
DRUG SAFETY;
ERYTHEMA;
FEMALE;
HUMAN;
HUMAN TISSUE;
LETTER;
LIVER METASTASIS;
LUNG METASTASIS;
PRIORITY JOURNAL;
SKIN BIOPSY;
SKIN DEFECT;
SKIN LUPUS ERYTHEMATOSUS;
Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy
Reed BR, Huff JC, Jones SK, et al. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med 1985; 103: 49-51.
Chen M, Crowson AN, Woofter M, et al. Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: Report of 4 cases. J Rheumatol 2004; 31: 818-820.
Subacute lupus erythematosus-like gyrate erythema. Report of a case associated with a breast cancer
Neumann R, Schmidt JB, Niebauer G. Subacute lupus erythematosus-like gyrate erythema. Report of a case associated with a breast cancer. Dermatologica 1986; 173: 146-149.
Subacute cutaneous lupus erythematosus associated with breast carcinoma
Schewach-Millet M, Shpiro D, Ziv R, Trau H. Subacute cutaneous lupus erythematosus associated with breast carcinoma. J Am Acad Dermatol 1988; 19: 406-408.